Draft:Osman Ahmed

American Interventional Radiologist From Wikipedia, the free encyclopedia

Osmanuddin Ahmed (commonly known as Osman Ahmed) is an American interventional radiologist, academic, and medical entrepreneur. He is a professor of radiology at the University of Utah and a former faculty member at the University of Chicago.[1] A Fellow of both the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), Ahmed has authored more than 150 peer-reviewed publications and leads an NIH-funded clinical study on genicular artery embolization (GAE) for knee osteoarthritis.[2]

Born
United States
OccupationsInterventional radiologist, academic, entrepreneur
Employer(s)Joint and Vascular Institute, Flow Medical, University of Utah
Quick facts Osmanuddin AhmedMD, FSIR, FCIRSE, Born ...
Osmanuddin Ahmed
MD, FSIR, FCIRSE
Born
United States
EducationUniversity of Illinois at Chicago College of Medicine (MD) University of Chicago Medical Center (residency);
Stanford University Medical Center (fellowship)
OccupationsInterventional radiologist, academic, entrepreneur
Employer(s)Joint and Vascular Institute, Flow Medical, University of Utah
Known forGenicular artery embolization; musculoskeletal embolization; Flow Medical
Medical career
ProfessionMedicine
FieldInterventional radiology
Close

Ahmed serves as the Chief Executive Officer of the Joint & Vascular Institute, an outpatient interventional radiology practice with locations in Libertyville, Illinois and Rockford, Illinois, offering minimally invasive procedures including musculoskeletal embolization, prostate artery embolization, uterine fibroid embolization, and hemorrhoid artery embolization.[1][3]

He is also a co-founder of Flow Medical, a University of Chicago -affiliated medical device company developing a next-generation catheter for pulmonary embolism treatment.[4]

Education and training

Ahmed received his Doctor of Medicine from the University of Illinois at Chicago College of Medicine.[5] He completed residency training in diagnostic radiology at the University of Chicago Medical Center in 2014, and subsequently undertook fellowship training in vascular and interventional radiology at Stanford University Medical Center.[6] He is board-certified in interventional radiology and diagnostic radiology by the American Board of Radiology, with certification obtained in 2017.[6]

Career

Academic career

Following his fellowship, Ahmed joined the faculty of the University of Chicago in the Section of Vascular and Interventional Radiology, where he was appointed Assistant Professor.[7] There he participated in multidisciplinary care teams, including a pulmonary embolism response team (PERT), and built a practice spanning interventional oncology, venous disease, and musculoskeletal embolization.[8] He later joined the University of Utah as a professor of radiology.[1]

Ahmed has been invited to speak at national and international conferences on interventional radiology, and has been recognized as a Key Opinion Leader in the field.[2]

Industry and entrepreneurship

In 2020, Ahmed and interventional cardiologist Dr. Jonathan Paul conceived a novel multi-function thrombolysis catheter for treating acute pulmonary embolism while practicing at the University of Chicago Medical Center.[4] This concept developed into Flow Medical, co-founded by Ahmed, Paul, and CEO Jennifer Fried, with support from the university's Polsky Center for Entrepreneurship and non-dilutive funding from the National Institutes of Health.[4][9]

Flow Medical's device is designed to perform pulmonary angiography to locate blood clots, mechanically disrupt them via an expanding nitinol scaffold, deliver thrombolytic agents, and simultaneously monitor pulmonary artery pressure — all from a single catheter.[9] The company was a runner-up for the 2024 MedTech Innovator accelerator grand prize.[9] In December 2023, Flow Medical raised an initial $2 million friends-and-family round;[10] in December 2024, the company closed a $5 million oversubscribed seed round led by UCM Ventures, the venture fund of UChicago Medicine — marking the fund's first direct investment in a medical technology startup.[4][11]

Research

Genicular artery embolization

Ahmed's primary research focus has been genicular artery embolization (GAE), a minimally invasive image-guided procedure for knee osteoarthritis that targets abnormal synovial neovascularity and the inflammatory pathways associated with joint pain.[12] In 2024, Ahmed served as lead author on the Society of Interventional Radiology's formal research reporting standards for GAE, published in the Journal of Vascular and Interventional Radiology, an internationally collaborative effort involving researchers from the United States, Europe, and Japan.[12]

Ahmed served as a junior investigator for the Society of Interventional Radiology Foundation's Research Consensus Panel on genicular artery embolization in 2021.[13] He leads an NIH-funded randomized clinical study evaluating the effectiveness of GAE for knee osteoarthritis and has performed hundreds of GAE procedures.[2][1]

He also authored a review article on the procedure in Seminars in Interventional Radiology and co-authored a comprehensive international review of GAE techniques and clinical outcomes.[14][15]

Interventional oncology

Ahmed has published on image-guided locoregional therapies for primary liver cancer, including transarterial radioembolization (TARE) with yttrium-90 microspheres for hepatocellular carcinoma (HCC).[16] His paper "Segmental Yttrium-90 Radioembolization as an Initial Treatment for Solitary Unresectable HCC," published in the Arab Journal of Interventional Radiology, was awarded the 2022 Article of the Year by the Pan Arab Interventional Radiology Society.[16] His research has also appeared in Radiology, CHEST, the Journal of the American College of Radiology, and the Journal of Surgical Oncology.[8]

Pulmonary embolism

Ahmed's clinical and translational research on venous thromboembolism and catheter-directed therapies for pulmonary embolism informed the founding of Flow Medical. The company received Small Business Innovation Research (SBIR) funding from the National Institutes of Health in support of this work.[17]

Recognition

Ahmed was awarded the 2022 Article of the Year by the Pan Arab Interventional Radiology Society for his research on yttrium-90 radioembolization for hepatocellular carcinoma.[16] He holds fellowship designations from both the Society of Interventional Radiology (FSIR) and the Cardiovascular and Interventional Radiological Society of Europe (FCIRSE).[1]

Selected publications

  • Ahmed, Osman; Epelboym, Yan; Haskal, Ziv J. (2024). "Society of Interventional Radiology Research Reporting Standards for Genicular Artery Embolization". Journal of Vascular and Interventional Radiology. 35 (8): 1097–1103. doi:10.1016/j.jvir.2024.04.018. PMID 38685470.

References

Related Articles

Wikiwand AI